Russell Investments Group
VYGR icon

Russell Investments Group’s Voyager Therapeutics VYGR Stock Holding History

Russell Investments Group’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.1K Buy
24,613
+20,559
+507% +$78K ﹤0.01% 3495
2026
Q1 		$15.6K Hold
4,054
– – ﹤0.01% 3682
2025
Q4 		$15.9K Hold
4,054
– – ﹤0.01% 3690
2025
Q3 		$18.9K Sell
4,054
-1,721
-30% -$6.23K ﹤0.01% 3602
2025
Q2 		$18K Hold
5,775
– – ﹤0.01% 3221
2025
Q1 		$19.5K Buy
+5,775
New +$27K ﹤0.01% 3116
2024
Q2 		– Sell
-43
Closed -$400 – 3630
2024
Q1 		$400 Buy
+43
New +$363 ﹤0.01% 3240
2021
Q4 		– Sell
-54,298
Closed -$141K – 3124
2021
Q3 		$141K Sell
54,298
-12,591
-19% -$40.9K ﹤0.01% 2834
2021
Q2 		$275K Sell
66,889
-54,510
-45% -$247K ﹤0.01% 2810
2021
Q1 		$571K Buy
121,399
+39,174
+48% +$267K ﹤0.01% 2469
2020
Q4 		$587K Sell
82,225
-4,320
-5% -$41.5K ﹤0.01% 2363
2020
Q3 		$923K Buy
86,545
+20,065
+30% +$236K ﹤0.01% 2106
2020
Q2 		$837K Sell
66,480
-6,807
-9% -$79.2K ﹤0.01% 2152
2020
Q1 		$667K Sell
73,287
-1,841
-2% -$21.1K ﹤0.01% 2048
2019
Q4 		$1.04M Buy
75,128
+67,064
+832% +$975K ﹤0.01% 2077
2019
Q3 		$139K Buy
+8,064
New +$169K ﹤0.01% 2737
2018
Q4 		– Sell
-5,097
Closed -$96K – 3041
2018
Q3 		$96K Hold
5,097
– – ﹤0.01% 2759
2018
Q2 		$101K Hold
5,097
– – ﹤0.01% 2739
2018
Q1 		$96K Sell
5,097
-3,161
-38% -$68.3K ﹤0.01% 2754
2017
Q4 		$140K Sell
8,258
-606
-7% -$10.4K ﹤0.01% 2728
2017
Q3 		$183K Sell
8,864
-3,000
-25% -$33.9K ﹤0.01% 2684
2017
Q2 		$106K Buy
11,864
+4,343
+58% +$43.7K ﹤0.01% 2797
2017
Q1 		$100K Sell
7,521
-7,388
-50% -$89.7K ﹤0.01% 2809
2016
Q4 		$194K Buy
+14,909
New +$191K ﹤0.01% 2724

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Russell Investments Group's VYGR Position: Q2 2026 in Review

Russell Investments Group increased its Voyager Therapeutics (VYGR) stake by 507% in Q2 2026, buying an estimated $78K and bringing the position to 24,613 shares worth $86.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3495.

Russell Investments Group first reported a position in VYGR in Q4 2016 and has held it in 24 quarters since. The position peaked at $1.04M in Q4 2019. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Russell Investments Group held 24,613 shares of Voyager Therapeutics worth $86.1K as of Q2 2026.
  • Russell Investments Group bought 20,559 Voyager Therapeutics shares in Q2 2026, an estimated $78K.
  • Voyager Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3495 holding.
  • Russell Investments Group first reported a position in Voyager Therapeutics in Q4 2016 and has held it in 24 quarters since.
  • Russell Investments Group's Voyager Therapeutics position peaked at $1.04M in Q4 2019.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.